Results 111 to 120 of about 19,002 (159)

Three-Month Outcome of Ziv-Aflibercept for Diabetic Macular Edema

Advances in Ophthalmology & Visual System, 2016
1.1.Purpose:Is to show the 3-month efficacy and safety of treatment diabetic macular edema treated with intravitreal ziv-aflibercept as studies have shown that Ziv-aflibercept does not cause retinal pigment epithelial toxicity and to study it cost effectiveness.
openaire   +1 more source

Intravitreal ziv-aflibercept for myopic macular neovascularization after pars plana vitrectomy and silicone oil tamponade: a case report. [PDF]

Ann Med Surg (Lond)
Abu Ghedda S, Aljundi R, Baba M, Marashi A.   +3 more
europepmc   +1 more source

The clinical utility of aflibercept for diabetic macular edema

, 2015
Michael W StewartDepartment of Ophthalmology, Mayo School of Medicine, Jacksonville, FL, USAAbstract: The treatment of center-involving diabetic macular edema (DME) has improved because of the proven efficacy of drugs that inhibit the effects of vascular
Stewart MW
core  

Three‐month outcomes of ziv‐aflibercept in the treatment of diabetic macular oedema [PDF]

Acta Ophthalmologica, 2016
Mohammed, Ashraf, Ahmed A R, Souka, Hassan, El Kayal, Mostafa, El Manhaly, Mohamed Hossam, Abdallah   +4 more
openaire   +2 more sources

A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors. [PDF]

Pancreas, 2019
Halperin DM, Lee JJ, Ng CS, Strosberg JR, Estrella JS, Dagohoy CG, Dasari A, Yao JC.   +7 more
europepmc   +1 more source

Iterative two-dimensional error concealment for low-complexity wireless video uplink transmitters

, 2012
Since joint source-channel decoding is capable of exploiting the residual redundancy in the encoded source signals for improving the attainable error resilience, it has attracted substantial attention.
Wang, Tao, Hanzo, Lajos, Huo, Yongkai, Maunder, Robert G.   +3 more
core  

Ziv-aflibercept combined with intravitreal steroid for management of peripheral exudative haemorrhagic chorioretinopathy. [PDF]

BMJ Case Rep, 2019
Balakrishnan D, Oli A.
europepmc   +1 more source

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G. [PDF]

Target Oncol
Matsumoto T, Yamamoto Y, Kotaka M, Masuishi T, Tsuji Y, Shoji H, Hirata K, Tsuduki T, Makiyama A, Izawa N, Takahashi N, Tsuda M, Yasui H, Ohta T, Kito Y, Otsu S, Hironaka S, Yamazaki K, Boku N, Hyodo I, Yoshimura K, Muro K.   +21 more
europepmc   +1 more source

Treatment outcomes of ziv‐aflibercept for treatment‐naïve polypoidal choroidal vasculopathy [PDF]

Acta Ophthalmologica, 2017
Errol W. Chan, Mohab Eldeeb, Vishal Govindhari, Chintan Sarvaiya, Alay Banker, Ahmad Mansour, Jay Chhablani   +6 more
openaire   +2 more sources

Efectividad del uso de tres dosis de ziv-aflibercept intravítreo en el tratamiento del edema macular diabético en un entorno de la vida real

Objetivo: Evaluar en un entorno de la vida real la eficacia del Ziv-Aflibercept intravítreo en el tratamiento del edema macular diabético (EMD) después de la administración de tres dosis mensuales consecutivas. Métodos: Estudio de cohorte prospectivo de
Munayco Guillén, Fernando
core